GH Research (GHRS)
NASDAQ: GHRS
· Real-Time Price · USD
10.40
-0.40 (-3.70%)
At close: May 09, 2025, 3:59 PM
10.38
-0.19%
After-hours: May 09, 2025, 04:05 PM EDT
-3.70% (1D)
| Bid | 9.62 |
| Market Cap | 645.09M |
| Revenue (ttm) | 80K |
| Net Income (ttm) | -38.96M |
| EPS (ttm) | -0.75 |
| PE Ratio (ttm) | -13.87 |
| Forward PE | -6.73 |
| Analyst | Buy |
| Ask | 11.23 |
| Volume | 57,103 |
| Avg. Volume (20D) | 234,908 |
| Open | 10.97 |
| Previous Close | 10.80 |
| Day's Range | 10.38 - 11.21 |
| 52-Week Range | 6.00 - 20.50 |
| Beta | 0.86 |
About GHRS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GHRS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GHRS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-9.28%
GH Research shares are trading lower after announc...
Unlock content with
Pro Subscription
3 months ago
+69.72%
GH Research shares are trading higher after the company's inhalable depression treatment GH001 met the primary endpoint in its Phase 2b trial, showing symptom reduction.
